BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 18483302)

  • 1. Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cells.
    D'Alise AM; Amabile G; Iovino M; Di Giorgio FP; Bartiromo M; Sessa F; Villa F; Musacchio A; Cortese R
    Mol Cancer Ther; 2008 May; 7(5):1140-9. PubMed ID: 18483302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis of reversine selectivity in inhibiting Mps1 more potently than aurora B kinase.
    Hiruma Y; Koch A; Dharadhar S; Joosten RP; Perrakis A
    Proteins; 2016 Dec; 84(12):1761-1766. PubMed ID: 27699881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Aurora B kinase activity is required for the maintenance of the differentiated state of murine myoblasts.
    Amabile G; D'Alise AM; Iovino M; Jones P; Santaguida S; Musacchio A; Taylor S; Cortese R
    Cell Death Differ; 2009 Feb; 16(2):321-30. PubMed ID: 18974773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the aurora kinase inhibitors AZD1152-HQPA and ZM447439 on growth arrest and polyploidy in acute myeloid leukemia cell lines and primary blasts.
    Walsby E; Walsh V; Pepper C; Burnett A; Mills K
    Haematologica; 2008 May; 93(5):662-9. PubMed ID: 18367484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferential killing of p53-deficient cancer cells by reversine.
    Jemaà M; Galluzzi L; Kepp O; Boilève A; Lissa D; Senovilla L; Harper F; Pierron G; Berardinelli F; Antoccia A; Castedo M; Vitale I; Kroemer G
    Cell Cycle; 2012 Jun; 11(11):2149-58. PubMed ID: 22592527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological characterization of TAK-901, an investigational, novel, multitargeted Aurora B kinase inhibitor.
    Farrell P; Shi L; Matuszkiewicz J; Balakrishna D; Hoshino T; Zhang L; Elliott S; Fabrey R; Lee B; Halkowycz P; Sang B; Ishino S; Nomura T; Teratani M; Ohta Y; Grimshaw C; Paraselli B; Satou T; de Jong R
    Mol Cancer Ther; 2013 Apr; 12(4):460-70. PubMed ID: 23358665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversine triggers mitotic catastrophe and apoptosis in K562 cells.
    Rodrigues Alves AP; Machado-Neto JA; Scheucher PS; Paiva HH; Simões BP; Rego EM; Traina F
    Leuk Res; 2016 Sep; 48():26-31. PubMed ID: 27447890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The aurora kinase inhibitor CCT137690 downregulates MYCN and sensitizes MYCN-amplified neuroblastoma in vivo.
    Faisal A; Vaughan L; Bavetsias V; Sun C; Atrash B; Avery S; Jamin Y; Robinson SP; Workman P; Blagg J; Raynaud FI; Eccles SA; Chesler L; Linardopoulos S
    Mol Cancer Ther; 2011 Nov; 10(11):2115-23. PubMed ID: 21885865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The FLT3 internal tandem duplication mutation is a secondary target of the aurora B kinase inhibitor AZD1152-HQPA in acute myelogenous leukemia cells.
    Grundy M; Seedhouse C; Shang S; Richardson J; Russell N; Pallis M
    Mol Cancer Ther; 2010 Mar; 9(3):661-72. PubMed ID: 20159992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversine exerts cytotoxic effects through multiple cell death mechanisms in acute lymphoblastic leukemia.
    Carlos JAEG; Lima K; Coelho-Silva JL; de Melo Alves-Paiva R; Moreno NC; Vicari HP; de Souza Santos FP; Hamerschlak N; Costa-Lotufo LV; Traina F; Machado-Neto JA
    Cell Oncol (Dordr); 2020 Dec; 43(6):1191-1201. PubMed ID: 32857324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding inhibitor resistance in Mps1 kinase through novel biophysical assays and structures.
    Hiruma Y; Koch A; Hazraty N; Tsakou F; Medema RH; Joosten RP; Perrakis A
    J Biol Chem; 2017 Sep; 292(35):14496-14504. PubMed ID: 28726638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antineoplastic effects of an Aurora B kinase inhibitor in breast cancer.
    Gully CP; Zhang F; Chen J; Yeung JA; Velazquez-Torres G; Wang E; Yeung SC; Lee MH
    Mol Cancer; 2010 Feb; 9():42. PubMed ID: 20175926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VX-680 inhibits Aurora A and Aurora B kinase activity in human cells.
    Tyler RK; Shpiro N; Marquez R; Eyers PA
    Cell Cycle; 2007 Nov; 6(22):2846-54. PubMed ID: 18032922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-Hydroxyflavone inhibits endogenous Aurora B and induces growth inhibition of cancer cell line.
    Lang Q; Zhang H; Li J; Xie F; Zhang Y; Wan B; Yu L
    Mol Biol Rep; 2010 Mar; 37(3):1577-83. PubMed ID: 19437133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth suppression and mitotic defect induced by JNJ-7706621, an inhibitor of cyclin-dependent kinases and aurora kinases.
    Matsuhashi A; Ohno T; Kimura M; Hara A; Saio M; Nagano A; Kawai G; Saitou M; Takigami I; Yamada K; Okano Y; Shimizu K
    Curr Cancer Drug Targets; 2012 Jul; 12(6):625-39. PubMed ID: 22463590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of an Aurora kinase inhibitor specific for the Aurora B isoform.
    Xie H; Lee MH; Zhu F; Reddy K; Peng C; Li Y; Lim DY; Kim DJ; Li X; Kang S; Li H; Ma W; Lubet RA; Ding J; Bode AM; Dong Z
    Cancer Res; 2013 Jan; 73(2):716-24. PubMed ID: 23117881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversine induces autophagic cell death through the AMP-activated protein kinase pathway in urothelial carcinoma cells.
    Fang CY; Chen JS; Chang SK; Shen CH
    Anticancer Drugs; 2018 Jan; 29(1):29-39. PubMed ID: 28984683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dietary flavonoid luteolin inhibits Aurora B kinase activity and blocks proliferation of cancer cells.
    Xie F; Lang Q; Zhou M; Zhang H; Zhang Z; Zhang Y; Wan B; Huang Q; Yu L
    Eur J Pharm Sci; 2012 Aug; 46(5):388-96. PubMed ID: 22449725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversine Induced Multinucleated Cells, Cell Apoptosis and Autophagy in Human Non-Small Cell Lung Cancer Cells.
    Lu YC; Lee YR; Liao JD; Lin CY; Chen YY; Chen PT; Tseng YS
    PLoS One; 2016; 11(7):e0158587. PubMed ID: 27385117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new small-molecule Aurora B inhibitor shows antitumor activity in human cancer cell lines.
    Wu Y; Li J; Jiang C; Yang X; Cao L; Yu L
    Mol Biol Rep; 2015 Feb; 42(2):517-24. PubMed ID: 25348602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.